202 related articles for article (PubMed ID: 30962447)
1. An artificial triazole backbone linkage provides a split-and-click strategy to bioactive chemically modified CRISPR sgRNA.
Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
Nat Commun; 2019 Apr; 10(1):1610. PubMed ID: 30962447
[TBL] [Abstract][Full Text] [Related]
2. "Split-and-Click" sgRNA.
Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
[TBL] [Abstract][Full Text] [Related]
3. Conjugation and Evaluation of Triazole-Linked Single Guide RNA for CRISPR-Cas9 Gene Editing.
He K; Chou ET; Begay S; Anderson EM; van Brabant Smith A
Chembiochem; 2016 Oct; 17(19):1809-1812. PubMed ID: 27441384
[TBL] [Abstract][Full Text] [Related]
4. Versatile 3' Functionalization of CRISPR Single Guide RNA.
Palumbo CM; Gutierrez-Bujari JM; O'Geen H; Segal DJ; Beal PA
Chembiochem; 2020 Jun; 21(11):1633-1640. PubMed ID: 31943634
[TBL] [Abstract][Full Text] [Related]
5. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
[TBL] [Abstract][Full Text] [Related]
6. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
Riesenberg S; Helmbrecht N; Kanis P; Maricic T; Pääbo S
Nat Commun; 2022 Jan; 13(1):489. PubMed ID: 35078986
[TBL] [Abstract][Full Text] [Related]
7. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
Basila M; Kelley ML; Smith AVB
PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
[TBL] [Abstract][Full Text] [Related]
8. Chemical Modifications in RNA Interference and CRISPR/Cas Genome Editing Reagents.
Lennox KA; Behlke MA
Methods Mol Biol; 2020; 2115():23-55. PubMed ID: 32006393
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Click Enables Dual-Gene Editing with Modular Synthetic sgRNAs.
Park H; Osman EA; Cromwell CR; St Laurent CD; Liu Y; Kitova EN; Klassen JS; Hubbard BP; Macauley MS; Gibbs JM
Bioconjug Chem; 2022 May; 33(5):858-868. PubMed ID: 35436106
[TBL] [Abstract][Full Text] [Related]
10. Tetrazine-Ligated CRISPR sgRNAs for Efficient Genome Editing.
Chen Z; Devi G; Arif A; Zamore PD; Sontheimer EJ; Watts JK
ACS Chem Biol; 2022 May; 17(5):1045-1050. PubMed ID: 35446558
[TBL] [Abstract][Full Text] [Related]
11. Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering.
Lee K; Mackley VA; Rao A; Chong AT; Dewitt MA; Corn JE; Murthy N
Elife; 2017 May; 6():. PubMed ID: 28462777
[TBL] [Abstract][Full Text] [Related]
12. Disrupting Protein Expression with Double-Clicked sgRNA-Cas9 Complexes: A Modular Approach to CRISPR Gene Editing.
Tijaro-Bulla S; Osman EA; St Laurent CD; McCord KA; Macauley MS; Gibbs JM
ACS Chem Biol; 2023 Oct; 18(10):2156-2162. PubMed ID: 37556411
[TBL] [Abstract][Full Text] [Related]
13. Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems.
Filippova J; Matveeva A; Zhuravlev E; Stepanov G
Biochimie; 2019 Dec; 167():49-60. PubMed ID: 31493470
[TBL] [Abstract][Full Text] [Related]
14. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
Graf R; Li X; Chu VT; Rajewsky K
Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
[TBL] [Abstract][Full Text] [Related]
15. A G-quadruplex motif at the 3' end of sgRNAs improves CRISPR-Cas9 based genome editing efficiency.
Nahar S; Sehgal P; Azhar M; Rai M; Singh A; Sivasubbu S; Chakraborty D; Maiti S
Chem Commun (Camb); 2018 Mar; 54(19):2377-2380. PubMed ID: 29450416
[TBL] [Abstract][Full Text] [Related]
16. Pinpoint modification strategy for stabilization of single guide RNA.
Takeuchi S; Yamamoto M; Matsumoto S; Kenjo E; Karashima M; Ikeda Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123149. PubMed ID: 35139474
[TBL] [Abstract][Full Text] [Related]
17. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
[TBL] [Abstract][Full Text] [Related]
18. Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells.
Shapiro J; Tovin A; Iancu O; Allen D; Hendel A
Methods Mol Biol; 2021; 2162():37-48. PubMed ID: 32926376
[TBL] [Abstract][Full Text] [Related]
19. Chimeric DNA-RNA Guide RNA Designs.
Lu S; Zhang Y; Yin H
Methods Mol Biol; 2021; 2162():79-85. PubMed ID: 32926379
[TBL] [Abstract][Full Text] [Related]
20. Partial DNA-guided Cas9 enables genome editing with reduced off-target activity.
Yin H; Song CQ; Suresh S; Kwan SY; Wu Q; Walsh S; Ding J; Bogorad RL; Zhu LJ; Wolfe SA; Koteliansky V; Xue W; Langer R; Anderson DG
Nat Chem Biol; 2018 Mar; 14(3):311-316. PubMed ID: 29377001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
